Huawei is continuing to move up the list of companies getting the most U.S. patents, according to a new study of patenting activity that shows Chinese firms are increasingly responsible for a greater share of the world’s innovation.
Huawei received 2,770 U.S. patents last year, putting it at No. 5 behind perennial top patent-getter International Business Machines Corp. according to the study by Fairview Research’s IFI Claims Patent Services.
Huawei’s success in obtaining patents comes even as its networking equipment is shut out of the American market and it’s been cut off from procuring components needed for its phones by the Biden administration. The U.S. government has accused the Shenzhen-based company of being a security threat, charges that Huawei denies.
Huawei jumped from ninth place in part because of declines by other companies as the U.S. Patent and Trademark Office issued 7% fewer patents last year. Samsung Electronics Co., Canon Inc. and Taiwan Semiconductor Manufacturing Co. rounded out the top five patent recipients.
Chinese companies also dominate when considering global patent ownership, according to the analytics firm. Samsung remains the biggest holder of patented inventions globally. But six Chinese entities, including Huawei and the Chinese Academy of Sciences, hold more patents on inventions than IBM, which ranks No. 8 on that list.
“Everywhere you turn, they seem to be establishing themselves, or seeking to establish themselves, as major players,” said IFI Claims Chief Executive Officer Mike Baycroft. “You hear these stories that the Chinese market is going to take over the world. Here, it’s starting to become real.”
Recently, Huawei also ranked second in the 2021 EU Industrial R&D Investment Scoreboard, up from third place in the previous year’s edition. The 2021 EU Industrial R&D Investment Scoreboard is a European Commission publication that ranks the research investment levels of 2,500 companies around the world that comprise 90% of the world’s business-funded R&D. The report is prepared by the EU Joint Research Centre (JRC).
-Ends-
© Press Release 2022
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
